WETTIG THANE (Chief Commercial Officer) reported 1 transaction at KYNTRA BIO, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/9/2025ACC: 0001815638-25-000005
Officer· Chief Commercial Officer
Since Jun 2020
-259.00
Net shares
Net seller
$2.2K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
259.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−259.00
Price / share
$8.42
Trade value
$2.18K
% of position
1.0%
12/6/2025
24.94K→24.68K
Total
Net shares
−259.00
Net value
-$2.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/6/2025 | F · Tax Withholding | −259.00 | $8.42 | $2.18K | 1.0% | 24.94K | 24.68K |
| Total | −259.00 | -$2.18K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned40.00
Total
40.00 indirect40.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 40.00 | Indirect |
| Total | 40.00 | 40.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported